American Portfolios Advisors - TEVA PHARMACEUTICAL FIN LLC ownership

TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 56 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
American Portfolios Advisors ownership history of TEVA PHARMACEUTICAL FIN LLC
ValueSharesWeighting
Q3 2022$1,593
-18.2%
2,0000.0%0.00%
Q2 2022$1,948
-0.4%
2,0000.0%0.00%
Q1 2022$1,955
+0.3%
2,0000.0%0.00%
Q4 2021$1,950
-0.8%
2,0000.0%0.00%
Q3 2021$1,966
-0.2%
2,0000.0%0.00%
Q2 2021$1,970
-1.3%
2,0000.0%0.00%
Q1 2021$1,996
+0.3%
2,0000.0%0.00%
Q4 2020$1,990
+2.5%
2,0000.0%0.00%
Q3 2020$1,941
+0.2%
2,0000.0%0.00%
Q2 2020$1,937
+4.6%
2,0000.0%0.00%
Q1 2020$1,851
-2.4%
2,0000.0%0.00%
Q4 2019$1,896
+4.7%
2,0000.0%0.00%
Q3 2019$1,811
-1.0%
2,0000.0%0.00%
Q2 2019$1,829
-0.8%
2,0000.0%0.00%
Q1 2019$1,844
+2.2%
2,0000.0%0.00%
Q4 2018$1,805
-3.5%
2,0000.0%0.00%
Q3 2018$1,871
+0.9%
2,0000.0%0.00%
Q2 2018$1,854
+5.8%
2,0000.0%0.00%
Q1 2018$1,753
-0.1%
2,0000.0%0.00%
Q4 2017$1,7552,0000.00%
Other shareholders
TEVA PHARMACEUTICAL FIN LLC shareholders Q4 2019
NameSharesValueWeighting ↓
ZAZOVE ASSOCIATES LLC 83,413,000$130,650,0006.13%
AEGON USA Investment Management, LLC 6,000,000$9,368,0002.35%
MACKAY SHIELDS LLC 24,370,000$38,152,0002.07%
INCOME RESEARCH & MANAGEMENT 4,374,000$6,829,0001.11%
KINGDON CAPITAL MANAGEMENT, L.L.C. 20,000$20,347,0000.99%
SHENKMAN CAPITAL MANAGEMENT INC 5,269,000$8,264,0000.82%
Mitsubishi UFJ Securities Holdings Co., Ltd. 325,000$511,0000.76%
PALISADE CAPITAL MANAGEMENT, LP 9,299,000$14,598,0000.47%
ADVENT CAPITAL MANAGEMENT /DE/ 14,543,000$23,021,0000.35%
CSS LLC/IL 3,750,000$5,893,0000.35%
View complete list of TEVA PHARMACEUTICAL FIN LLC shareholders